MAS
GILD icon

MPWM Advisory Solutions’s Gilead Sciences GILD Stock Holding History

MPWM Advisory Solutions’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$30.7K Hold
220
– – 0.02% 235
2025
Q4 		$27K Hold
220
– – 0.02% 225
2025
Q3 		$24.4K Hold
220
– – 0.01% 220
2025
Q2 		$24.4K Hold
220
– – 0.02% 217
2025
Q1 		$24.7K Hold
220
– – 0.02% 209
2024
Q4 		$20.3K Buy
+220
New +$19.8K 0.01% 244

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

MPWM Advisory Solutions's GILD Position: Q1 2026 in Review

MPWM Advisory Solutions held its Gilead Sciences (GILD) position steady in Q1 2026 at 220 shares worth $30.7K. The position accounts for 0.02% of the portfolio, ranked #235.

MPWM Advisory Solutions first reported a position in GILD in Q4 2024 and has held it in 6 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • MPWM Advisory Solutions held 220 shares of Gilead Sciences worth $30.7K as of Q1 2026.
  • MPWM Advisory Solutions left its Gilead Sciences share count unchanged in Q1 2026.
  • Gilead Sciences made up 0.02% of MPWM Advisory Solutions's portfolio in Q1 2026, its #235 holding.
  • MPWM Advisory Solutions first reported a position in Gilead Sciences in Q4 2024 and has held it in 6 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on MPWM Advisory Solutions's 13F filing for Q1 2026, filed 13 May 2026.